Nathalie Rouas-Freiss

Title: Nathalie Rouas-Freiss: Innovator in HLA-G Molecule Research

Introduction

Nathalie Rouas-Freiss is a notable inventor based in Paris, France, recognized for her significant contributions to the field of HLA-G molecules and their therapeutic applications. With a total of four patents, she has paved the way for advancements in medical treatments targeting various diseases.

Latest Patents

One of her latest patents, titled "HLA-G transcripts and isoforms and their uses," explores novel HLA-G isoforms—new RNA transcripts and proteins derived from the HLA-G gene. This patent includes details on pharmaceutical compositions utilizing these isoforms, as well as specific primers and antibodies. Another important patent focuses on the "HLA-G isoform for use in the treatment of a disease associated with bone resorption," highlighting the innovative use of HLA-G isoforms in preventing and treating conditions linked to bone loss.

Career Highlights

Nathalie has worked with prominent research institutions, including the Commissariat à l'Énergie Atomique and the Commissariat à l'Énergie Atomique et aux Énergies Alternatives. Her work has significantly advanced the understanding of HLA-G molecules and their therapeutic potentials, marking her as a leader in her field.

Collaborations

Throughout her career, Nathalie has collaborated with esteemed colleagues such as Edgardo Delfino Carosella and Jean Dausset. These collaborations have further enhanced the impact of her research, facilitating breakthroughs in the diagnostic and therapeutic applications of HLA-G molecules.

Conclusion

Nathalie Rouas-Freiss continues to drive innovation in the medical research community, particularly in the application of HLA-G molecules. Her patents are a testament to her commitment to improving health outcomes through scientific discovery and innovation.